STADA and Alvotech receive positive CHMP opinion for Europe's first ustekinumab biosimilar to Stelara - Alvotech (NASDAQ:ALVO)
CHMP positive opinion in the European Economic Area for first biosimilar to Stelara, a biologic therapy within gastroenterology, dermatology and rheumatologyPositive CHMP opinion for Uzpruvo biosimilar is based on